466 related articles for article (PubMed ID: 11531292)
1. High sensitivity of PCR in situ hybridization for the detection of human papillomavirus infection in uterine cervical neoplasias.
Xiao Y; Sato S; Oguchi T; Kudo K; Yokoyama Y; Saito Y
Gynecol Oncol; 2001 Aug; 82(2):350-4. PubMed ID: 11531292
[TBL] [Abstract][Full Text] [Related]
2. Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method.
Huang CC; Qiu JT; Kashima ML; Kurman RJ; Wu TC
Mod Pathol; 1998 Oct; 11(10):971-7. PubMed ID: 9796725
[TBL] [Abstract][Full Text] [Related]
3. Frequent detection of human papilloma viruses in cervical dysplasia by PCR single-strand DNA-conformational polymorphism analysis.
Nakagawa H; Sugano K; Fujii T; Kubushiro K; Tsukazaki K; Nozawa S
Anticancer Res; 2002; 22(3):1655-60. PubMed ID: 12168850
[TBL] [Abstract][Full Text] [Related]
4. [Detection of human papillomavirus types 16 and 18 DNA sequences in the screening of the cells related with carcinoma in situ of the uterine cervix--application of in situ hybridization for cytologic diagnosis].
Nagai N; Kioka H; Shigemasa K; Shinko Y; Fujiwara A
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Sep; 40(9):1393-9. PubMed ID: 2844927
[TBL] [Abstract][Full Text] [Related]
5. Detection of human papillomavirus in cervical carcinoma: comparison of peroxidase, Nanogold, and catalyzed reporter deposition (CARD)-Nanogold in situ hybridization.
Cheung AL; Graf AH; Hauser-Kronberger C; Dietze O; Tubbs RR; Hacker GW
Mod Pathol; 1999 Jul; 12(7):689-96. PubMed ID: 10430273
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
7. [Detection of HPV-DNA in the various uterocervical lesion by the in situ polymerase chain reaction].
Ishi K; Kina K; Koyatsu J; Kawashima T; Suzuki F; Saito A; Kubota T; Igari J
Rinsho Byori; 1997 Jan; 45(1):82-6. PubMed ID: 9022348
[TBL] [Abstract][Full Text] [Related]
8. Detection and typing of human papillomavirus in cervical cancer in the Thai.
Bhattarakosol P; Poonnaniti A; Niruthisard S
J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S56-64. PubMed ID: 9071068
[TBL] [Abstract][Full Text] [Related]
9. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
10. [Detection of multiple human papillomavirus infection in cervical specimens by flow fluorescent hybridization].
Chen QY; Bian ML; Zhang XY; Ou H; Ma L
Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):901-5. PubMed ID: 19671291
[TBL] [Abstract][Full Text] [Related]
11. [Detection of human papillomavirus DNA in cervical squamous cell carcinoma in Xinjiang Uygur women].
Suzuk L; Noffsinger AE; Aili M
Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):405-8. PubMed ID: 9639725
[TBL] [Abstract][Full Text] [Related]
12. Periodic health examination, 1995 update: 1. Screening for human papillomavirus infection in asymptomatic women. Canadian Task Force on the Periodic Health Examination.
Johnson K
CMAJ; 1995 Feb; 152(4):483-93. PubMed ID: 7859196
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous detection of antigens and specific DNA sequences of human papillomavirus in uterine cervical biopsy specimens. Description of a double-labelling technique.
Gómez F; Roldán M; Corcuera MT; Picazo A; Muñoz E; Alonso MJ
Eur J Histochem; 1997; 41(4):255-9. PubMed ID: 9491311
[TBL] [Abstract][Full Text] [Related]
14. A new nonisotopic detection of human papillomavirus DNA using polymerase chain reaction.
Binninger I; Clavel C; Polette M; Boutterin MC; Chypre C; Alpha B; Birembaut P
Diagn Mol Pathol; 1992 Dec; 1(4):239-45. PubMed ID: 1342972
[TBL] [Abstract][Full Text] [Related]
15. Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma.
Dong SM; Pai SI; Rha SH; Hildesheim A; Kurman RJ; Schwartz PE; Mortel R; McGowan L; Greenberg MD; Barnes WA; Sidransky D
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):3-6. PubMed ID: 11815394
[TBL] [Abstract][Full Text] [Related]
16. A comparison of early (E7) and late (L1) primer-mediated amplification of papillomaviral DNA in cervical neoplasia.
Tate JE; Yang YC; Shen J; McLachlin CM; Sheets EE; Crum CP
Mol Cell Probes; 1996 Oct; 10(5):347-51. PubMed ID: 8910889
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus in early laryngeal carcinoma.
Baumann JL; Cohen S; Evjen AN; Law JH; Vadivelu S; Attia A; Schindler JS; Chung CH; Wirth PS; Meijer CJ; Snijders PJ; Yarbrough WG; Slebos RJ
Laryngoscope; 2009 Aug; 119(8):1531-7. PubMed ID: 19489068
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus in cell samples from Stockholm Gynecologic Health Screening.
Hagmar B; Kalantari M; Skyldberg B; Moberger B; Johansson B; Walaas L; Wärleby B
Acta Cytol; 1995; 39(4):741-5. PubMed ID: 7631548
[TBL] [Abstract][Full Text] [Related]
20. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
